Inventors:
Qiang Ye - San Diego CA, US
Ryan Hart - San Diego CA, US
Robert Kania - San Diego CA, US
Michael Ouellette - San Diego CA, US
Zhen Wu - La Jolla CA, US
Scott Zook - San Diego CA, US
International Classification:
A61K 31/4439
C07D 403/02
Abstract:
The present invention relates to novel polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a hyperproliferative disorder or a mammalian disease condition mediated by protein kinase activity.